F025 Come on Rounds with Us!
DESCRIPTION
This session will provide a rapid-fire tour of the most educational inpatient dermatology cases from the past year, presented by a cadre of inpatient dermatologists. Presenters will represent a broad geographic swath of the United States and include junior, mid-career, and senior inpatient dermatologists. Each presenter will share one case along with 1–3 key teaching pearls focused on diagnoses and morphologies encountered in hospitalized patients. At the conclusion of the session, attendees will vote on the most educational case presentation.
LEARNING OBJECTIVES
Recognize key morphologies and diagnoses encountered in hospitalized patients through representative inpatient dermatology cases.
Apply high-yield diagnostic and management pearls from inpatient dermatology consultations to clinical practice.
Identify common diagnostic pitfalls and practice gaps in the evaluation of dermatologic disease in the hospital setting.
DIRECTOR
Lindy Peta Fox, MD, FAAD
University of California, San Francisco
SPEAKERS
Nina Blank, MD, FAAD
Steven T. Chen, MD, MPH, FAAD
MassGeneral Brigham/Harvard Medical School
Madeline DeWane, MD, FAAD
Sotonye Imadojemu, MD, FAAD
Caroline Nelson, MD, FAAD
Cuong Nguyen, MD, FAAD
Helena Beth Pasieka, MD
Nathan Rojek, MD, FAAD
DISCLOSURES
Nina Blank, MD, FAAD
No financial relationships exist with ineligible companies.
Steven T. Chen, MD, MPH, FAAD
AbbVie – Advisory Board(Honoraria); Vertex Pharmaceuticals Incorporated – Employee (w-2 relationship)(Salary); VisualDx – Independent Contractor(Fees);
Madeline DeWane, MD, FAAD
Veradermics Inc – Stockholder Public Company(No Compensation Received);
Lindy Peta Fox, MD, FAAD
Vetted Dermlab – Founder(Stock);
Sotonye Imadojemu, MD, FAAD
No financial relationships exist with ineligible companies.
Caroline Nelson, MD, FAAD
Boehringer Ingelheim – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Cuong Nguyen, MD, FAAD
No financial relationships exist with ineligible companies.
Helena Beth Pasieka, MD
No financial relationships exist with ineligible companies.
Nathan Rojek, MD, FAAD
Novartis Pharmaceuticals Corporation – Advisory Board(Honoraria), Speaker(Fees);